Administration of ACEI or ARB in chronic kidney disease patients with concomitant SARS-CoV-2 respiratory infection

Med Clin (Barc). 2021 Oct 8;157(7):e295-e296. doi: 10.1016/j.medcli.2021.03.014. Epub 2021 May 7.

[Article in English, Spanish]

Authors

Cristina Mateo Gómez¹, Jorge Martínez Del Río², Jesús Piqueras Flores²

Affiliations

¹ Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España. Electronic address: [email protected].
² Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, España.

No abstract available

Publication types

Letter

MeSH terms

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
COVID-19*
Humans
Renal Insufficiency, Chronic* / complications
SARS-CoV-2

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors